UK markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.61-0.09 (-0.35%)
As of 03:35PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-132,527
-132,527
-289,088
-370,638
-194,592
Depreciation & amortisation
20,012
20,012
14,147
7,451
4,735
Stock-based compensation
98,647
98,647
84,321
43,570
15,380
Change in working capital
-116,455
-116,455
251,628
111,254
5,347
Accounts payable
-7,578
-7,578
2,373
818
60
Other working capital
-182,927
-182,927
-26,424
-113,079
-112,098
Other non-cash items
-221
-221
-10,471
158,860
10,388
Net cash provided by operating activities
-149,195
-149,195
22,527
-66,268
-95,741
Cash flows from investing activities
Investments in property, plant and equipment
-33,732
-33,732
-48,951
-46,811
-16,357
Purchases of investments
-984,338
-984,338
-1,616,999
-777,223
-282,362
Sales/maturities of investments
1,089,910
1,089,910
1,204,614
529,270
198,596
Net cash used for investing activities
71,840
71,840
-461,336
-294,144
-100,123
Cash flows from financing activities
Debt repayment
-2,252
-2,252
-2,287
-2,118
-1,569
Common stock issued
270,168
270,168
108,258
757,449
319,528
Other financing activities
-631
-631
-188
-8,816
-2,059
Net cash used provided by (used for) financing activities
276,448
276,448
111,590
756,141
322,322
Net change in cash
199,093
199,093
-327,219
395,729
126,458
Cash at beginning of period
245,521
245,521
572,740
177,011
50,553
Cash at end of period
444,614
444,614
245,521
572,740
177,011
Free cash flow
Operating cash flow
-149,195
-149,195
22,527
-66,268
-95,741
Capital expenditure
-33,732
-33,732
-48,951
-46,811
-16,357
Free cash flow
-182,927
-182,927
-26,424
-113,079
-112,098